Clinical and Pathologic Phenotyping of mesotheliomas developing in carriers of Germline BAP1 Mutations

August 11, 2025 | Comments Off on Clinical and Pathologic Phenotyping of mesotheliomas developing in carriers of Germline BAP1 Mutations

Journal of Thoracic Oncology 2025 June 27 [Link] Michele Carbone, Michael Minaai, Muaiad Kittaneh, Thomas Krausz, Markku M Miettinen, Qiang Pan Hammarström, Lennart Hammarström, Hassan Abolhassani, Ian Pagano, Ronghui Xu,…

Immune Composition and Immunotherapy Outcomes of Mesothelioma with BAP1, CDKN2A, MTAP, and NF2 Alterations

August 8, 2025 | Comments Off on Immune Composition and Immunotherapy Outcomes of Mesothelioma with BAP1, CDKN2A, MTAP, and NF2 Alterations

Journal of Thoracic Oncology 2025 June 25 [Link] Ibiayi Dagogo-Jack, Owen Mitchell, Elizabeth Codd, Annie Li, Dawn Mitchell, Samantha E Flynn, Nanna Sivamanoharan, Patrick Reeves, Mark Poznansky, Ivan Valiev, Artem…

HMGB1 as a Key Mediator in Malignant Mesothelioma and a Potential Target for Asbestos-Related Cancer Therapy

August 7, 2025 | Comments Off on HMGB1 as a Key Mediator in Malignant Mesothelioma and a Potential Target for Asbestos-Related Cancer Therapy

Toxics 2025 May 28 [Link] Yi-Fang Zhong, Chan Ding, Chun-Ji Yao, Jia-Chun Wang, Min-Qian Feng, Xiao-Xue Gong, Lin Yu, Hua-Dong Xu, Hai-Ling Xia Abstract Malignant mesothelioma (MM) is a highly…

Loss of MTAP expression is not an accurate surrogate for CDKN2A homozygous deletions in peritoneal mesothelioma

August 6, 2025 | Comments Off on Loss of MTAP expression is not an accurate surrogate for CDKN2A homozygous deletions in peritoneal mesothelioma

Histopathology 2025 June 25 [Link] Andrea Quaranta, Andrea Marzullo, Francesco Fortarezza, Sonia Maniglio, Concetta Caporusso, Floriana Pentimone, Federica Pezzuto, Domenica Cavone, Teresa Lettini, Mario Magistro, Cecilia Salzillo, Luigi Vimercati, Paolo…

Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case Series

August 5, 2025 | Comments Off on Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case Series

JTO Clinical Case Reports 2025 April 21 [Link] Illaa Smesseim, Paul Baas, Jacobus A Burgers Abstract The CheckMate 743 trial established nivolumab and ipilimumab as the standard first-line treatment for…

8C7: A Fully Human Anti-PTGFRN Monoclonal Antibody-Drug Conjugate Inhibiting Tumour Growth of Mesothelioma and Paediatric Medulloblastoma Cell Lines

August 4, 2025 | Comments Off on 8C7: A Fully Human Anti-PTGFRN Monoclonal Antibody-Drug Conjugate Inhibiting Tumour Growth of Mesothelioma and Paediatric Medulloblastoma Cell Lines

Journal of Cellular and Molecular Medicine 2025 June [Link] Jorge Marquez, Jianping Dong, Binbin Yue, Jun Hayashi, Chun Dong, Mitsuo Oshimura, Ginette Serrero Abstract Antibody Drug Conjugates (ADCs) are attractive…

PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma

August 1, 2025 | Comments Off on PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma

Cancer Science 2025 June 24 [Link] Kazumi Hori, Ichidai Tanaka, Tatsuhiro Sato, Mika Sato, Yuta Kodama, Hideyuki Itoigawa, Yuichi Abe, Taketo Kato, Ayumu Taguchi, Mitsuo Sato, Yoshitaka Sekido, Toyofumi Fengshi…

Fibulin-3 in plasma and pleural effusion as a biomarker of mesothelioma

July 31, 2025 | Comments Off on Fibulin-3 in plasma and pleural effusion as a biomarker of mesothelioma

Radiology and Oncology 2025 June 16 [Link] Katja Adamic, Mateja Marc Malovrh, Urska Bidovec Stojkovic, Ales Rozman Abstract Background: Malignant pleural mesothelioma (MPM) is a global health concern linked to…

Impact of Multimodal Surgical Resection and Personalized Targeted Therapy on Survival Outcomes in Early-Stage Malignant Pleural Mesothelioma: A Meta-Analysis

July 30, 2025 | Comments Off on Impact of Multimodal Surgical Resection and Personalized Targeted Therapy on Survival Outcomes in Early-Stage Malignant Pleural Mesothelioma: A Meta-Analysis

Cureus 2025 May 22 [Link] Alexis Quetzalcoatl Vega Morales, Jorge Luis Rivera Gastelum, Alfonso J Massé Ponce, Alexis Agustin A Dunay Silva, Emiliano Banda Dávila, Andrea Virginia Rivera Aguirre, Odalys…

Current and future applications of artificial intelligence in lung cancer and mesothelioma

July 29, 2025 | Comments Off on Current and future applications of artificial intelligence in lung cancer and mesothelioma

Thorax 2025 June 20 [Link] Joshua J Roche, Farzaneh Seyedshahi, Kai Rakovic, Akari Win Thu, John Le Quesne, Kevin G Blyth Abstract Background: Considerable challenges exist in managing lung cancer…

Categories